Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T16:17:11.588Z.
Calculation as of: 2026-10-06T16:17:11.588Z.
Quote observation: 2026-10-06T16:15:07.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e4c5e5530b5f4ff9b2ae64c4564a307684e7c74323ce66c5db527ab157f5d0a0
PEG RATIO
N/A
IceCure Medical Ltd
Market Cap
$3.13M
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| IceCure Medical Ltd (ICCM) | $3.13M | N/A |
| MBody AI Ltd. (MBAI)vs › | $3.16M | N/A |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.07M | N/A |
| Revelation Biosciences, Inc. (REVB)vs › | $3.04M | N/A |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.26M | N/A |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.26M | N/A |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.00M | N/A |
| Aethlon Medical, Inc. (AEMD)vs › | $3.27M | N/A |
| Moolec Science S.A. (MLEC)vs › | $3.39M | N/A |
| Eocene Ltd. (EOCN)vs › | $3.48M | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
